CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations
- 31 July 1998
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 153 (1), 159-163
- https://doi.org/10.1016/s0002-9440(10)65556-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Alterations of the p15, p16, and p18 genes in osteosarcomaCancer Genetics and Cytogenetics, 1996
- Growth suppression by p16ink4 requires functional retinoblastoma protein.Proceedings of the National Academy of Sciences, 1995
- The retinoblastoma gene is involved in malignant progression of astrocytomasAnnals of Neurology, 1994
- Chromosome analysis of nine osteosarcomasGenes, Chromosomes and Cancer, 1994
- Cytogenetic findings in 33 osteosarcomasInternational Journal of Cancer, 1993
- Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcomaCancer Genetics and Cytogenetics, 1991
- Analysis of Alterations in the Retinoblastoma Gene and Tumor Grade in Bone and Soft-Tissue SarcomasJNCI Journal of the National Cancer Institute, 1991
- Complex karyotypes in a series of pediatric osteosarcomasCancer Genetics and Cytogenetics, 1989
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcomaNature, 1986
- Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition.Proceedings of the National Academy of Sciences, 1985